This Week in Otolaryngology — Jul 31, 2026

Welcome to This Week in Otolaryngology. This week we're covering 10 notable papers spanning head and neck oncology optimization, diagnostic and surgical advancements in otology and neurotology, and comparative safety profiles in sleep and orthognathic surgery. Let's dive in.

We begin in head and neck oncology, where optimizing treatment protocols and care pathways remains a major focus. A network meta-analysis published in The Laryngoscope compared non-surgical organ-preservation strategies for patients with locally advanced or resectable laryngeal and hypopharyngeal squamous cell carcinoma [1]. This study synthesized data from 15 randomized controlled trials involving 4,395 patients across 13 different strategies. For laryngeal preservation, concurrent cisplatin-based chemoradiotherapy ranked highest, followed closely by induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by radiotherapy, and radiotherapy combined with cetuximab. Notably, all non-surgical strategies outperformed surgery combined with postoperative radiotherapy for laryngeal preservation, reducing the hazard of laryngeal loss by nearly two-thirds. When looking at overall survival, induction chemotherapy with cisplatin and fluorouracil followed by radiotherapy showed the highest probability of benefit, though credible intervals overlapped among the leading regimens. For locoregional control, sequential induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by radiotherapy ranked best. The authors conclude that while concurrent cisplatin-based chemoradiotherapy remains the most consistent organ-preservation option, treatment must be individualized based on patient comorbidities and functional goals.

To further advance precision oncology, the American Head and Neck Society published a review in JAMA Otolaryngology-Head and Neck Surgery on the emerging role of circulating tumor DNA and oncogenic viral DNA as biomarkers in head and neck cancer [2]. Despite decades of research, reliable biomarkers have remained elusive. With the rising incidence of human papillomavirus-associated oropharyngeal cancer and Epstein-Barr virus-associated nasopharyngeal cancer, liquid biopsies targeting viral circulating tumor DNA are showing promise in diagnostic and surveillance settings. This review highlights how ongoing clinical trials are evaluating these biomarkers to monitor treatment response, detect minimal residual disease, and adapt therapeutic decisions. However, the authors caution that several hurdles remain before routine clinical implementation, including test variability and the clinical implications of inaccurate test results, highlighting the need for optimized trial designs.

Improving oncology outcomes also depends on the timing of adjuvant therapy delivery. A retrospective study in Otolaryngology-Head and Neck Surgery evaluated the impact of implementing oncology nurse navigators on the time to postoperative radiation therapy for patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma undergoing transoral robotic surgery [4]. In this study of 99 patients, implementing a dedicated nurse navigator reduced the median time from surgery to the initiation of radiation therapy from 50 to 44 days. This improvement was particularly pronounced among patients who received adjuvant chemoradiotherapy, those undergoing proton beam therapy, and those treated within an integrated academic health system. For patients receiving proton beam therapy, the rate of initiating radiation within the recommended six-week window rose from under 7% to over 38%. Furthermore, the proportion of patients who completed their entire adjuvant treatment package within 100 days of surgery increased from roughly 62% to 93%, demonstrating that dedicated nurse navigation is highly effective for mitigating systemic delays.

We round out our oncology discussion with a study in Head and Neck that challenges a widely used quality metric: lymph node yield in oral cavity squamous cell carcinoma [7]. The study analyzed 809 patients across two head and neck centers to determine if a universal lymph node yield cut-off could serve as a reliable quality metric for neck dissections. The researchers compared conventional pathological assessment via inspection and palpation against step serial sectioning. They found that the mean lymph node yield differed significantly between the two centers and was highly dependent on the pathology technique used, with step serial sectioning producing the highest mean yields. Paradoxically, a higher lymph node yield achieved through step serial sectioning was associated with worse survival, and the researchers were unable to establish a reliable universal cut-off that correlated with optimal survival outcomes. This study highlights that lymph node yield is heavily influenced by center-specific variables and pathology processing techniques, suggesting that universal thresholds may not be appropriate and that center-specific quality metrics are needed instead.

Turning to otology and neurotology, we start with a diagnostic challenge: screening for vestibular schwannoma in patients with asymmetric hearing loss. A systematic review published in Otology and Neurotology evaluated the diagnostic accuracy of non-imaging screening tools used to guide magnetic resonance imaging referrals [3]. Analyzing 20 studies that included over 9,000 patients and 1,169 confirmed cases of vestibular schwannoma, the authors evaluated pure tone audiometry, auditory brainstem response testing, vestibular testing, and audiometric configuration. They found a clear inverse relationship between sensitivity and specificity in audiometric threshold protocols. While lower thresholds achieved sensitivity levels approaching 100%, they suffered from very low specificity, which would lead to a high volume of unnecessary magnetic resonance imaging scans. Conversely, stricter criteria improved specificity but reduced sensitivity below the 90% threshold that is clinically acceptable for screening. Auditory brainstem response testing demonstrated high sensitivity in some cohorts but was unreliable for detecting smaller tumors of 10 millimeters or less. The authors conclude that while audiometric protocols remain our best first-line screening tools, no single non-imaging test consistently achieves both high sensitivity and specificity.

For patients diagnosed with symptomatic superior semicircular canal dehiscence and third-window syndrome, a retrospective study in The Laryngoscope provides encouraging surgical data [8]. The researchers evaluated the cochleovestibular outcomes of 20 patients who underwent trans-mastoid superior semicircular canal occlusion using autogenous periosteum, temporalis fascia, bone pate, and fibrin sealant. Preoperatively, patients suffered from significant symptoms, including hearing loss in 95%, autophony in 85%, and the Tullio phenomenon in 70% of cases, along with an elevated mean air-bone gap of 25 decibels. Following surgery, all patients reported symptomatic improvement, with complete resolution of the Tullio phenomenon. Objectively, the mean air-bone gap improved to just over 4 decibels while speech recognition was fully preserved. Postoperative objective testing showed normalization of both ocular vestibular evoked myogenic potentials and electrocochleography ratios. While video head impulse testing did reveal a reduction in gain within the operated canal, caloric responses remained unchanged, demonstrating that trans-mastoid occlusion is highly effective at restoring third-window physiology while preserving overall hearing and vestibular function.

In pediatric otology, the timing of intervention is critical. A long-term longitudinal study published in the International Journal of Pediatric Otorhinolaryngology followed 494 children who received cochlear implants for severe-to-profound sensorineural hearing loss [6]. Examining 588 implanted ears with up to 10 years of follow-up, the researchers stratified the children by age at implantation. They found that earlier implantation was the strongest predictor of superior long-term speech recognition scores. Children who received their implants before 12 months of age achieved the highest outcomes, with 100% of them reaching speech recognition scores greater than 75% at the 10-year mark. In contrast, children implanted between 9 and 10 years of age demonstrated significantly lower performance. Prior hearing aid use also correlated with better long-term outcomes, particularly from 6 years of follow-up onward, and the use of perimodiolar electrode designs was associated with superior early performance and remained an independent predictor of higher 10-year scores. Multivariable analysis confirmed that only younger age at implantation and electrode array type were independently associated with these long-term results.

We also have new data on predicting the recurrence of lateral semicircular canal benign paroxysmal positional vertigo, which can recur in up to half of patients within 10 years. A retrospective cohort study of 259 patients published in The Laryngoscope investigated whether the slow-phase velocity of positional nystagmus, measured via videonystagmography at initial diagnosis, could predict recurrence [10]. The researchers found that patients who experienced a recurrence had significantly higher initial slow-phase velocities and lower serum calcium levels than those who did not. Binomial logistic regression confirmed that both initial slow-phase velocity and low serum calcium were independent predictors of recurrence. Interestingly, the initial slow-phase velocity did not correlate with the velocity or timing of the recurrent episode, suggesting that recurrences represent independent otolithic events. The authors suggest that measuring slow-phase velocity at initial diagnosis provides a novel, routine parameter to help clinicians stratify recurrence risk and tailor patient follow-up.

Our final neurotology paper explores the intersection of artificial intelligence and clinical administration. A retrospective cohort study in The Laryngoscope compared the coding accuracy and financial impact of an institutional large language model against centralized human coders for 124 consecutive neurotology operative notes [9]. Using a surgeon-adjudicated reference standard, the large language model achieved a significantly higher coding accuracy of over 86%, compared to just over 49% for human coders. Human coders demonstrated a systematic tendency to under-code complex procedures, leading to a mean negative relative value unit variance of over 5 units per note, whereas the large language model had a variance of under 1 unit. This human under-coding represented an average loss of over 17% of the reference standard relative value units. Extrapolated to a five-surgeon division, this under-coding projected an annual revenue loss of over $145,000. The authors propose a hybrid model, where large language model-generated draft codes are verified by specialty-trained coders, to optimize both coding accuracy and revenue integrity in complex surgical specialties.

In our final theme, we look at the comparative safety profiles of major maxillofacial procedures. A systematic review and meta-analysis published in Otolaryngology-Head and Neck Surgery compared the complications and recovery metrics of maxillomandibular advancement for obstructive sleep apnea against orthognathic surgeries for dentofacial deformities [5]. Analyzing data from over 6,000 patients across multiple studies, the researchers found that while maxillomandibular advancement offered a high surgical success rate of nearly 80%, it was associated with a significantly longer mean operative time of approximately 344 minutes compared to 327 minutes for bimaxillary orthognathic surgery. Maxillomandibular advancement also required a longer postoperative hospital stay of over 4 days compared to just over 3 days for bimaxillary surgery. While neurosensory disturbances were comparable between the two groups, maxillomandibular advancement carried a much higher rate of postoperative infection, at over 16% compared to under 4% for bimaxillary surgery, and a higher rate of hardware removal, at nearly 22% compared to just over 4%. Additionally, the analysis revealed that postoperative obstructive sleep apnea developed in over 12% of patients undergoing bimaxillary surgery for dentofacial deformities. These findings highlight the importance of detailed preoperative counseling and risk stratification to balance efficacy and complication risks.

If you only have time for one paper this week, make it the systematic review of audiological criteria for vestibular schwannoma screening from Otology and Neurotology [3]. This paper is our top pick because it directly addresses a daily clinical challenge for every practicing otolaryngologist: balancing the diagnostic necessity of identifying a vestibular schwannoma with the high cost and resource utilization of magnetic resonance imaging, proving that we still need highly tailored, prospective protocols rather than relying on inconsistent retrospective criteria.

Here are the key takeaways from this week in Otolaryngology: First, for locally advanced laryngohypopharyngeal cancers, concurrent cisplatin-based chemoradiotherapy remains the most consistent non-surgical organ-preservation strategy, though induction chemotherapy regimens may offer distinct advantages for locoregional control or overall survival. Second, implementing oncology nurse navigators can significantly reduce delays in initiating postoperative radiation therapy, helping a vast majority of patients complete their adjuvant treatment within the recommended 100-day window. Third, when counseling pediatric cochlear implant candidates, remember that implantation before 12 months of age, combined with perimodiolar electrode selection, yields the highest and least variable long-term speech recognition outcomes. Fourth, maxillomandibular advancement for sleep apnea offers high success rates but carries a significantly higher risk of postoperative infection and hardware removal compared to standard bimaxillary orthognathic surgery. And finally, utilizing large language models to assist with operative note coding in complex subspecialties like neurotology can dramatically reduce human under-coding and prevent substantial revenue loss.

That's your roundup for This Week in Otolaryngology. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And if you have a paper you have been meaning to read, upload the PDF, or paste any link, at audioscholar dot C C. We will turn it into audio like this one, in any of thirty-one languages.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.